Fluigent's brand ambassadors
Want to visit Fluigent’s products in your university? Contact Fluigent’s brand ambassador!
In need of help, don’t hesitate to contact Fluigent’s corresponding sales representative.
Ambassador may reject the product visit request from the researchers who are out of Ambassador’s own university.
Dr. Colin J Chu 🇬🇧
University College London
Prof. Artem Mishchenko 🇬🇧
University of Manchester
Dr. Huizhi Wang 🇬🇧
Imperial College London
Dr. Mootaz Salman 🇬🇧
University of Oxford
🇬🇧 University College London
Dr Colin J Chu
Colin is an academic ophthalmologist at UCL Institute of Ophthalmology funded by the Wellcome Trust as a Clinical Research Career Development Fellow.
He was an undergraduate at the University of Cambridge prior to medical school at Oxford University and undertook his PhD at UCL with Prof Robin Ali. Subsequently he moved to the University of Bristol as a NIHR Academic Clinical Lecturer working with Prof Andrew Dick.
He has spent time in the US at the University of Rochester hosted by Dr Jesse Schallek and as a Fulbright scholar at the National Institutes of Health working with Dr Ron Germain on advanced tissue imaging approaches.
His ongoing research spans gene therapy and in vivo imaging of immune cells using adaptive optics, OCT and fluorescent dye labelling to better understand ocular inflammation.
He is an Honorary Consultant Ophthalmologist at Moorfields Eye Hospital with his clinical practice in Uveitis.
“As a clinician and immunologist with an interest in imaging, I was involved in developing a new technique for multiplexed immunohistochemistry. We wanted to automate the process by adding a microfluidic solution, but I had no experience with this technology. The ARIA system fit our needs and was incredibly simple and intuitive to use. The software is well-designed and readily interfaced with our microscope. Fluigent provided support throughout setup and transformed what seemed a large undertaking, into an incredibly simple task.”
Colin Chu, University College London
🇬🇧 University of Manchester
Prof. Artem Mishchenko
Artem Mishchenko is a professor of condensed matter physics, Faculty of Science and Engineering, University of Manchester. He got PhD in Molecular Electronics in 2010 at the Faculty of Science, Bern University, Switzerland. He is a leading expert in physics of van der Waals materials. His research is centred on quantum phenomena in a large variety of systems: from quantum transport in van der Waals materials to molecules and ion transport to the structure of water in confined geometries.
He has published over 100 papers, nearly half in high-profile journals such as Science, Nature and Nature group, PNAS, Nano Letters, and PRL. His h-index is 49, with >27000 citations, according to Google Scholar.
He has been selected Highly Cited Researcher by Clarivate Analytics for the past five years – from 2018 to 2022. He has been recognised internationally – he received the prestigious EMFL Prize in 2018 and the Blavatnik Award for Young Scientists in 2021, for “Revealing unusual quantum phenomena in vertical, multilayer stacks of two-dimensional materials, in particular those that hold great potential in the development of novel electronic transistors for light-emitting diodes (LEDs), high-speed electronics, and information storage.” He has secured major external funding, including the highly prestigious ERC Consolidator Grant (2020-2025), and EPSRC Early Career Fellowship (2016-2021).
“We are really happy with Flugent microfluidics control systems: they are very EZ to use; they are also robust and reliable. We want to highlight in particular the user-friendliness of the software (OxyGEN), and the ease with which one can implement their own third-party programs to embed Fluigent controllers to a bigger setup comprising multiple units from different manufacturers. .”
Prof. Artem Mischenko, University of Manchester
🇬🇧 Imperial College London
Dr. Huizhi Wang
Huizhi Wang is a senior lecturer in the Department of Mechanical Engineering and a member of the Electrochemical Science & Engineering Group. She received her PhD in Mechanical Engineering from the University of Hong Kong in 2012. She then worked at the University of Hong Kong as a postdoctoral fellow until 2014. Prior to joining Imperial College, she was an assistant professor in the School of Engineering and Physical Sciences at Heriot-Watt University, Edinburgh.
Her research interest lies in electrochemical energy engineering with a particular focus on the thermofluid aspects of electrochemical energy conversion and storage systems including fuel cells, batteries and electrolysers. She is also interested in advanced manufacturing (e.g., microfluidic-based fabrication, additive manufacturing) and diagnostic techniques for electrochemical energy applications.
She has over 100 journal publications and 8 patents. Her research is supported by EPSRC, EU H2020, Scottish Funding Council and industrial sponsors.
“We came to Fluigent when we were building an automated microfluidic platform for screening chemical reactions. Fluigent products are powerful in precise control of the flow conditions and can guarantee the performance of our platform. The pump system is user-friendly and can be extended to complex experimental systems where multiple pumps are needed. The above merits have made our experimental design process smooth and easy.”
Dr. Huizhi Wang, Imperial College London
🇬🇧 University of Oxford
Dr. Mootaz Salman
After graduating with a Bachelor of Pharmacy with Honours (BPharm(Hons)) from the University of Mosul, I studied for Masters and Doctoral degrees at Sheffield Hallam University. Working with Professor Nicola Woodroofe and Dr Matthew Conner, my PhD project investigated the mechanisms of water channel translocation in human brain cells. I discovered a novel pharmacological framework for developing new drugs to treat traumatic brain injury, brain oedema and stroke.
I held my first postdoctoral fellowship at Harvard Medical School and Boston Children’s Hospital working with Professor Tom Kirchhausen. The project was in collaboration with Biogen®. I aimed to understand the cellular physiology of the blood-brain barrier (BBB) in order to exploit the mechanisms involved in improving the effectiveness of therapeutic antibodies. The project involved developing an in vitro microphysiological 3D model that can be used for multiple high-resolution imaging modalities. I used transmission electron microscopy (TEM), 3D live fluorescence imaging, spinning disk confocal microscopy and advanced lattice light sheet microscopy (LLSM) to study the trans-BBB trafficking of fluorescently-labelled therapeutic proteins and antibodies.
I joined the Wade-Martins group in late 2020. As part of Oxford Parkinson’s Disease Centre (OPDC), the aim of my project was to contribute to the development of novel therapeutic target discovery for Parkinson’s. I used CRISPR/Cas9 genome engineering of highly physiologically-relevant human iPSC lines from Parkinson’s patients differentiated into dopaminergic neurons to investigate molecular disease mechanisms and validate new therapeutic hits. The project was in collaboration with GSK® which offered an exciting opportunity to work at the translational interface of academic and industry target discovery and drug development.
I am a Research Lecturer and Leverhulme Trust Fellow. I am interested in investigating mechanisms of blood-brain barrier (dys)function in neurodegenerative diseases using patient-derived stem cells, gene editing (CRISPR-Cas 9) and organ-on-a-chip technologies.
For more information or a technical discussionContact us